• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • T Regulatory Cell Therapies
      • SOD1 Therapies & Trials
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • Diagnostic Delay (in development)
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Meeting
    • Allied Professionals Forum
    • Alliance Webinars
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • Patient Fellows Program
    • Global CRLI
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Staff

CEO

Catherine Cummings, CAE, MBA

Catherine CummingsCathy Cummings has an eclectic mix of work experiences in the Canadian not-for-profit sector including the National Payroll Institute, the Canadian Bar Association, the Canadian Corporate Counsel Association, and now as the Executive Director of the International Alliance of ALS/MND Associations. Cathy has also volunteered extensively with United Way, the Canadian Society of Association Executives and many charities, including ALS Ontario, ALS Canada and Ceridian Cares. She holds an MBA from Athabasca University and is a Certified Association Executive (CAE) designation.

On a personal note, Cathy is married to her wonderful husband Marty, has three awesome children and has a mission nicknamed the “Bouquet Project,” where she is trying to reverse the statistic that people are 10 times more likely to complain than praise.

To contact Catherine, please email cathy.cummings@als-mnd.org.

Contract Staff

The International Alliance works with various contractors across the globe to achieve its mission of a world free of ALS/MND. These contractors work in unison with our Executive Director to operate the Alliance. Read more about each contractor below: 

Advocacy and Membership Lead

David Ali

 
David is an experienced CEO and Board member across several different environments. He also has an extensive background in social policy, communications, strategy development and implementation, relationship building and engagement, advocacy, organizational performance, industry reviews and investigations.
 
When asked around 23 years ago to join the MND Victoria Board, David had never heard of ALS/MND, let alone understood the cruel disease it is.  Since then, he has volunteered in many ways including raising awareness, fundraising, and being on the Board of Directors of MND Victoria, MND Australia and the International Alliance of ALS/MND Associations.  David was until March 2024 the Chief Executive Officer of MND Australia. 
 
David lives in Melbourne, Australia – year-after-year rated one of the world’s most livable cities.  Time away from work is spent with family, enjoying running and his home city.
 
To contact David, please email david.ali@als-mnd.org. 
 

Innovation and Technology Lead

Jarnail Chudge

Jarnail Chudge was a Design and Innovation Architect in the Enable Group at Microsoft Technology + Research where he worked on projects where the primary focus is to design, develop, and deliver empowering and inclusive experiences which are sustainable, enhance human awareness, and augment a person’s intelligence by amplifying it and which allow the space to create and develop new skills and capabilities. As the co-founder of Microsoft Soundscape, which uses 3D spatial audio to created audio Augmented Reality, Jarnail has had special focus on how a product built on inclusive design principles primarily for the Blind and Low-Vision community, can have universal value for everyone by demonstrating the broader value of the technology in a range of different scenarios.

Jarnail started his career in academia focusing on the burgeoning field of socio-technical systems where he gained first-hand experience of integrating business, user, and technology needs. Making the switch to industry Jarnail has extensive international experience across a range of industry sectors, both as an individual contributor and also as a team-leader and manager. Jarnail’s work on the Enable team on Microsoft Soundscape and on “Hands-Free” which uses eye-control technology, is characterized by a philosophy grounded in building sustainable business ecosystems based on internal and external collaborations where the value-exchange between the different stakeholders is based on mutual benefit and ultimately, the impact on the user.

Scientific Director

Martina de Majo, PhD

Martina de Majo, PhD, has extensive experience researching disease mechanisms of ALS/MND and Frontotemporal Dementia (FTD). Dr. de Majo earned her Bachelor’s degree in Biotechnology and Master’s degree in Pharmaceutical Biotechnology with honours from the Sapienza University of Rome (Italy). She then received her PhD in Clinical Neuroscience from King’s College London (UK) and completed her postdoctoral training at University of California, San Francisco (USA).

In addition to her academic training, Dr. de Majo worked as a principal investigator in the industry sector, directing several National Institutes of Health projects around ALS/FTD disease in vitro modelling. She joined the Alliance as Scientific Director in 2024 and has been coordinating the Alliance research portfolio since.

To contact Martina, please email martina.demajo@als-mnd.org

Program Coordinator

Jessica Mabe

Jessica Mabe was born in London and had a bilingual upbringing in Bogotá, Colombia. She relocated to the UK after finishing school, where she completed her university degree in French & German with Business Studies  at the Aberystwyth University in Wales, followed by a Masters in Mass Communications at Leicester University (UK), Masters in Digital Marketing and Advertising at the University of Nebrija (Spain), and a Masters in Digital Marketing from the EAN University (Colombia). Jessica developed her skills as a sales and digital marketing professional leading teams in the UK and Ireland in the technology sector.

In 2014, Jessica’s mother got diagnosed with bulbar onset ALS/MND, and she decided to return to Colombia early in 2015 to help care for her alongside her father. Her mother passed away on February 21, 2018, and shortly after she joined ACELA, the Colombian ALS/MND Association, as an active volunteer supporting family caregivers in their ALS/MND journey. In July 2021, she joined the Alliance as Programs Coordinator.   

To contact Jessica, please email jessica.mabe@als-mnd.org.

Executive Assistant

Liana Maltby, CAP

Liana Maltby is a skilled administrative support professional who has experience in research and preparation of meeting agendas and minutes, scheduling, and meeting and event planning.  She achieved her Certified Administrative Professional (CAP) certificate through the International Association of Administrative Professionals.

Before joining the Alliance Team in 2022, Liana had a successful career serving in numerous roles with the same employer for over 37 years.  As an Executive Assistant, she supported a provincial Board of Directors and members of a provincial association.  She interacted and built strong relationships with municipal and provincial government officials and was involved in government lobby days advocating for legislative change.  Most recently, Liana was elected as Municipal Councillor in her local community.  

Liana, along with her husband and eldest daughter live in Ontario, Canada, and their youngest daughter lives in Alberta, Canada.

To contact Liana, please email liana.maltby@als-mnd.org.

Strategic Project Manager

Julia Simon, BCom

Julia Simon has a Bachelor of Commerce in Marketing from the John Molson School of Business in Montreal, Canada. Most recently, Julia worked in open source community building the technology industry. In 2019, she experienced a major burnout, which eventually led her to share her story through conference talks about normalizing mental health issues and advocating for systemic change in the workplace. She is a human-centric generalist who is authentically curious. Julia is a multilinguist (English, French, German, Spanish) and loves to connect with people in a meaningful way.

When her father was diagnosed with bulbar onset ALS-FTD in January 2022, she became one of his primary caregivers. He passed away in April of the same year, which led her to learn about death positivity, medical assistance in dying and end-of-life care. She has since taken courses in peer support work as well as being an end-of-life doula.  Julia spends her down time with her son, Felix, and her cat, Flash.

To contact Julia, please email julia.simon@als-mnd.org.

Communications Manager

Lynne Yryku

Lynne Yryku is a versatile communications manager known for her professional approach and attention to detail. With a background in English-French-Spanish translation and over 15 years of experience, Lynne has worked with diverse associations on project ranging from print publications to marketing campaigns to website management systems. Her ability to understand member needs and translate them into engaging content with practical takeaways for her clients sets her apart. Through her work with the Alliance, she strives to share the vision of a world free of ALS/MND with millions of people worldwide.

Lynne lives in Ontario, Canada, where she is Mom to creatures two- and four-legged. She is an outdoor enthusiast who loves running, camping, kayaking, biking and exploring nature with her husband and kids.

To contact Lynne, please email lynne.yryku@als-mnd.org.

Primary Sidebar

About

  • Who We Are
  • Board of Trustees
  • Advisory Councils/Committees
    • PALS and CALS Advisory Council
    • Innovation and Technology Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Archives
    • Newsletters
    • Meetings
  • Awards

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Josée Kolijn-de Man, Diagnosed 2015 , ALS Patients Connected, The Netherlands

    Josée Kolijn-de Man, Diagnosed 2015 , ALS Patients Connected, The Netherlands

  • David Solomon, Diagnosed 2015, MND Association of England, Wales and N Ireland

    David Solomon, Diagnosed 2015, MND Association of England, Wales and N Ireland

  • Chen Yin Xue, Taiwan MND Association, Diagnosed 1995, Taiwan

    Chen Yin Xue, Taiwan MND Association, Diagnosed 1995, Taiwan

  • Enzo Maccarrone, AISLA ONLUS, Italy

    Enzo Maccarrone, AISLA ONLUS, Italy

  • Sally Pauls, Diagnosed 2006 , Les Turner ALS Foundation

    Sally Pauls, Diagnosed 2006 , Les Turner ALS Foundation

  • Dawn Morton, Diagnosed 2014 , MND Scotland, UK

    Dawn Morton, Diagnosed 2014 , MND Scotland, UK

  • Norm MacIsaac,  ALS Society of Canada,  ALS Society of Quebec,  Diagnosed 2014

    Norm MacIsaac, ALS Society of Canada, ALS Society of Quebec, Diagnosed 2014

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Peng Yi-Wen

    Peng Yi-Wen

  • Mauril Belanger

    Mauril Belanger

  • Wendy Hendrickson, ALS Hope Foundation, USA

    Wendy Hendrickson, ALS Hope Foundation, USA

  • Liong Ting Ngu, MND Malaysia, Diagnosed 2014

    Liong Ting Ngu, MND Malaysia, Diagnosed 2014

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Susan Keldani, Les Turner ALS Foundation, USA

    Susan Keldani, Les Turner ALS Foundation, USA

  • Laurie Petit-Jean, Diagnosed 2012 , ARSLA, France

    Laurie Petit-Jean, Diagnosed 2012 , ARSLA, France

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Michael Lee, Australia

    Michael Lee, Australia

  • Bjarne Hytjanstorp, ALS Norge, Norway

    Bjarne Hytjanstorp, ALS Norge, Norway

  • Verónica Isabel Castro Molina, Diagnosed 2014, Argentina

    Verónica Isabel Castro Molina, Diagnosed 2014, Argentina

  • Frank "Papa" Taylor

    Frank “Papa” Taylor

  • Xian-Zhang Niu, Diagnosed 2006 , Shaanxi ALS Association, China

    Xian-Zhang Niu, Diagnosed 2006 , Shaanxi ALS Association, China

  • IMG_2658

    IMG_2658

  • Dick Dayton, USA

    Dick Dayton, USA

  • Lachlan Terry,  MND Australia,  Diagnosed 2015

    Lachlan Terry, MND Australia, Diagnosed 2015

  • Orlando Ruiz, Diagnosed 2001,  ACELA, Colombia

    Orlando Ruiz, Diagnosed 2001, ACELA, Colombia

  • 83

    83

  • Paul Launer, USA

    Paul Launer, USA

  • Graham Johnson, MND Australia

    Graham Johnson, MND Australia

  • Maria Santos Garcia Tellez, Diagnosed 2017 , FYADENMAC, Mexico

    Maria Santos Garcia Tellez, Diagnosed 2017 , FYADENMAC, Mexico

  • Angie Bordaen, Diagnosed 2014,  ALS Liga België, Belgium

    Angie Bordaen, Diagnosed 2014, ALS Liga België, Belgium

  • Richard Clark, MND New Zealand,  Diagnosed 2011

    Richard Clark, MND New Zealand, Diagnosed 2011

  • Ian and Teresa Roberts

    Ian and Teresa Roberts

  • Duncan Bayly , MND Australia

    Duncan Bayly , MND Australia

  • H. Todd Kelly, Diagnosed 2013 , ALS Hope Foundation, USA

    H. Todd Kelly, Diagnosed 2013 , ALS Hope Foundation, USA

  • Sébastien Batiot, Diagnosed 2012 , ARSLA, France

    Sébastien Batiot, Diagnosed 2012 , ARSLA, France

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Dad

    Dad

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Jorge Melo, ABrELA, Brazil

    Jorge Melo, ABrELA, Brazil

  • Fabio Carvalho, Associação Pró-Cura da ELA, Brazil

    Fabio Carvalho, Associação Pró-Cura da ELA, Brazil

  • Bayley, Australia

    Bayley, Australia

  • Ailsa Malcolm-Hutton, Diagnosed 2013,  MND Association of England, Wales and N Ireland

    Ailsa Malcolm-Hutton, Diagnosed 2013, MND Association of England, Wales and N Ireland

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Yolanda Armendariz, Diagnosed 2017 , FYADENMAC, Mexico

    Yolanda Armendariz, Diagnosed 2017 , FYADENMAC, Mexico

  • Mauril Bélanger, Diagnosed 2015 , ALS Canada

    Mauril Bélanger, Diagnosed 2015 , ALS Canada

  • Joy Blakeley, Diagnosed 2017 , MND Australia

    Joy Blakeley, Diagnosed 2017 , MND Australia

  • Ana María Zavala, FYADENMAC, Diagnosed 2019, Mexico

    Ana María Zavala, FYADENMAC, Diagnosed 2019, Mexico

Learn more about the March of Faces

Latest Tweets

  • Just now

Footer

Subscribe to our Bi-Monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2025 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login